| Year |
Citation |
Score |
| 2023 |
Thaker AA, McConnell BV, Rogers DM, Carlson NE, Coughlan C, Jensen AM, Lopez-Paniagua D, Holden SK, Pressman PS, Pelak VS, Filley CM, Potter H, Adriana Solano D, Heffernan KS, Bettcher BM. Astrogliosis, neuritic microstructure, and sex effects: GFAP is an indicator of neuritic orientation in women. Brain, Behavior, and Immunity. PMID 37394144 DOI: 10.1016/j.bbi.2023.06.026 |
0.691 |
|
| 2023 |
Holden SK, Bettcher BM, Filley CM, Lopez-Paniagua D, Pelak VS. Posterior white matter integrity and self-reported posterior cortical symptoms using the Colorado Posterior Cortical Questionnaire. Frontiers in Neurology. 14: 1072938. PMID 36816576 DOI: 10.3389/fneur.2023.1072938 |
0.458 |
|
| 2022 |
Holden SK, Pelak VS, Sooy T, Heffernan KS, McConnell BV, Pressman PS, Bettcher BM. Development of the Colorado posterior cortical questionnaire within an Alzheimer's disease study cohort. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 35913095 DOI: 10.1080/13803395.2022.2105820 |
0.696 |
|
| 2022 |
Kletenik I, Holden SK, Sillau SH, O'Connell N, MacGillivray L, Mack J, Haddock B, Ashworth Dirac M, David AS, Nicholson TR, Attaripour Isfahani SN, Maurer CW, Lidstone SC, Hallett M, LaFaver K, et al. Gender disparity and abuse in functional movement disorders: a multi-center case-control study. Journal of Neurology. PMID 35098346 DOI: 10.1007/s00415-021-10943-6 |
0.7 |
|
| 2021 |
Macchi ZA, Kletenik I, Olvera C, Holden SK. Psychiatric Comorbidities in Functional Movement Disorders: A Retrospective Cohort Study. Movement Disorders Clinical Practice. 8: 725-732. PMID 34307745 DOI: 10.1002/mdc3.13226 |
0.715 |
|
| 2019 |
Holden SK, Bettcher BM, Pelak VS. Update on posterior cortical atrophy. Current Opinion in Neurology. PMID 31688098 DOI: 10.1097/Wco.0000000000000767 |
0.388 |
|
| 2019 |
Holden SK, Van Dok E, Pelak VS. Co-occurrence of Convergence Insufficiency and Cognitive Impairment in Parkinsonian Disorders: A Pilot Study. Frontiers in Neurology. 10: 864. PMID 31447772 DOI: 10.3389/Fneur.2019.00864 |
0.347 |
|
| 2019 |
Holden SK, Sheffler J, Stewart R, Thompson S, Persson J, Finseth T, Sillau S, Kluger BM. Feasibility of Home-Based Neurologic Music Therapy for Behavioral and Psychological Symptoms of Dementia: A Pilot Study. Journal of Music Therapy. PMID 31346625 DOI: 10.1093/Jmt/Thz009 |
0.316 |
|
| 2019 |
Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM. Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison. Parkinsonism & Related Disorders. PMID 31253494 DOI: 10.1016/J.Parkreldis.2019.06.018 |
0.376 |
|
| 2019 |
Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, ... ... Holden S, et al. Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings. Alzheimer's Research & Therapy. 11: 23. PMID 30867052 DOI: 10.1186/S13195-019-0476-1 |
0.391 |
|
| 2018 |
Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM. Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30306618 DOI: 10.1002/Mds.27487 |
0.32 |
|
| 2018 |
Holden SK, Finseth T, Sillau SH, Berman BD. Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort. Movement Disorders Clinical Practice. 5: 47-53. PMID 29662921 DOI: 10.1002/Mdc3.12553 |
0.325 |
|
| 2018 |
Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP. Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29488270 DOI: 10.1002/Mds.27323 |
0.362 |
|
| 2018 |
Boeve BF, Armstrong M, Galvin JE, Goldman J, Irwin DJ, Kaufer D, Leverenz JB, Lunde AM, McKeith IG, Paulson HL, Siderowf AD, Barrett MJ, Kimiko D, Duda J, Galasko DR, ... ... Holden SK, et al. O5-03-04: The Lewy Body Dementia Association Research Centers Of Excellence Program: Toward Optimizing Clinical Care And Clinical Trial Infrastructure Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.3010 |
0.377 |
|
| 2017 |
Kluger BM, Persenaire MJ, Holden SK, Palmer LT, Redwine H, Berk J, Anderson CA, Filley CM, Kutner J, Miyasaki J, Carter J. Implementation issues relevant to outpatient neurology palliative care. Annals of Palliative Medicine. PMID 29307208 DOI: 10.21037/Apm.2017.10.06 |
0.444 |
|
| 2016 |
Holden SK, Jones WE, Baker KA, Boersma IM, Kluger BM. Outcome measures for Parkinson's disease dementia: a systematic review. Movement Disorders Clinical Practice. 3: 9-18. PMID 26998505 DOI: 10.1002/Mdc3.12225 |
0.354 |
|
| 2015 |
Goldman JG, Holden S, Ouyang B, Bernard B, Goetz CG, Stebbins GT. Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests? Movement Disorders : Official Journal of the Movement Disorder Society. 30: 402-6. PMID 25449653 DOI: 10.1002/Mds.26084 |
0.309 |
|
| 2014 |
Goldman JG, Holden S. Treatment of psychosis and dementia in Parkinson's disease. Current Treatment Options in Neurology. 16: 281. PMID 24464490 DOI: 10.1007/S11940-013-0281-2 |
0.336 |
|
| 2006 |
Holden SK, Van Dok EL, Pelak VS. P2-298: CONVERGENCE INSUFFICIENCY AND COGNITIVE IMPAIRMENT IN PARKINSONIAN DISORDERS Alzheimer's & Dementia. 14: P796-P796. DOI: 10.1016/J.Jalz.2018.06.987 |
0.331 |
|
| Show low-probability matches. |